Rosuampin (YHP1701) / Yuhan Corp - LARVOL DELTA

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia (clinicaltrials.gov) - P=N/A | N=5047 | Completed | Sponsor: Yuhan Corporation | Active, not recruiting ➔ Completed

Trial completion • Cardiovascular • Dyslipidemia • Hypertension • Metabolic Disorders

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia (clinicaltrials.gov) - P=N/A | N=5047 | Active, not recruiting | Sponsor: Yuhan Corporation

New trial • Cardiovascular • Dyslipidemia • Hypertension • Metabolic Disorders

CORONA: Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (clinicaltrials.gov) - P4 | N=259 | Completed | Sponsor: Yuhan Corporation | Recruiting ➔ Completed

Combination therapy • Trial completion • Cardiovascular • Dyslipidemia • Hypertension • Metabolic Disorders

Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 (clinicaltrials.gov) - P3; N=106; Completed; Sponsor: Yuhan Corporation; Recruiting ➔ Completed; Trial completion date: Jan 2018 ➔ Apr 2018; Trial primary completion date: Dec 2017 ➔ Apr 2018

Trial completion • Trial completion date • Trial primary completion date • Biosimilar • Cardiovascular • Dyslipidemia • Hypertension